Not Cleared Direct

DEN180017 - Quantra Hemostasis Analyzer, QPlus Cartridge (FDA 510(k) Clearance)

Mar 2019
Decision
344d
Days
Class 2
Risk

DEN180017 is an FDA 510(k) submission for the Quantra Hemostasis Analyzer, QPlus Cartridge. This device is classified as a Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (Class II - Special Controls, product code QFR).

Submitted by Hemosonics, LLC (Charlottesville, US). The FDA issued a Not Cleared (DENG) decision on March 12, 2019.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5430. A Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties Is An In Vitro Diagnostic Device Used To Evaluate Blood Coagulation, Fibrinolysis, Or Both, In Patients..

Submission Details

510(k) Number DEN180017 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received April 02, 2018
Decision Date March 12, 2019
Days to Decision 344 days
Submission Type Direct
Review Panel Hematology (HE)
Summary -

Device Classification

Product Code QFR - Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5430
Definition A Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties Is An In Vitro Diagnostic Device Used To Evaluate Blood Coagulation, Fibrinolysis, Or Both, In Patients.